玮俊生物科技(00660)预计中期净亏损不超600万港元

Group 1 - The company, Wei Jun Biotechnology (00660), expects a net loss of no more than HKD 6 million for the six months ending December 31, 2025, which represents a significant reduction compared to a net loss of approximately HKD 13.1 million for the six months ending December 31, 2024 [1] - The substantial decrease in loss is primarily attributed to an increase in revenue and a reduction in financial costs during the reporting period [1]